Article
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.
Pharmacogenetics and genomics - 1 May 2014
Montes Ariana, Perez-Pampin Eva, Narváez Javier, Cañete Juan D, Navarro-Sarabia Federico, Moreira Virginia, Fernández-Nebro Antonio, Del Carmen Ordóñez María, de la Serna Arturo R, Magallares Berta, Vasilopoulos Yiannis, Sarafidou Theologia, Caliz Rafael, Ferrer Miguel Angel, Joven Beatriz, Carreira Patricia, Gómez-Reino Juan J, Gonzalez Antonio
Abstract excerpt
OBJECTIVES: We aimed to assess a functional polymorphism in FCGR2A H131R, for association with the treatment response to Fc-containing inhibitors of tumor necrosis factor (TNF). METHODS: A total of 429 biologic-naive patients with rheumatoid arthritis collected in two sets (299 and 130) were treated during standard care with infliximab (INX), etanercept, or adalimumab. Response to the treatment was evaluated at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
